SER Price / Book | Serina Therapeutics, Inc.

Serina Therapeutics, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Serina Therapeutics, Inc. price/book ratio for the quarter ending 2026-06-30 was 2.66, a 93.01% decline year-over-year.
Serina Therapeutics, Inc. price/book ratio for the quarter ending 2026-03-31 was 1.64, a 95.46% decline year-over-year.
Serina Therapeutics, Inc. price/book ratio for the quarter ending 2025-12-31 was -560.18, a 702.85% decline year-over-year.
Serina Therapeutics, Inc. price/book ratio for the quarter ending 2025-09-30 was 35.25, a change of 39.56 year-over-year.
Serina Therapeutics, Inc. price/book ratio for fiscal 2026 was 2.66.
Serina Therapeutics, Inc. price/book ratio for fiscal 2025 was -560.18, a 702.85% decline from fiscal 2024.
Serina Therapeutics, Inc. price/book ratio for fiscal 2024 was 92.92, a change of 93.95 from fiscal 2023.
Serina Therapeutics, Inc. price/book ratio for fiscal 2023 was -1.03, a change of -0.46 from fiscal 2022.

Available history: 2018-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.66	$49.78M	$18.73M
2026-03-31	1.64	$28.9M	$17.63M
2025-12-31	-560.18	$20.73M	-$37,000.00
2025-09-30	35.25	$56.19M	$1.59M
2025-06-30	38.03	$62.59M	$1.65M
2025-03-31	36.12	$56.31M	$1.56M
2024-12-31	92.92	$47.2M	$508,000.00
2024-09-30	-4.3	$59.49M	-$13.83M
2024-06-30	-5.14	$84.23M	-$16.39M
2024-03-31	-3.99	$113.25M	-$28.39M
2023-12-31	-1.03	$33.14M	-$32.29M
2023-09-30	-27.64	$921.67M	-$33.35M
2023-06-30	-34.3	$1.21B	-$35.29M
2023-03-31	-24.88	$898.63M	-$36.12M
2022-12-31	-0.56	$21.27M	-$37.78M
2022-09-30	-50.28	$761.65M	-$15.15M
2022-06-30	-58.86	$780.59M	-$13.26M
2022-03-31	-99.84	$1.16B	-$11.59M
2021-12-31	-124.38	$1.48B	-$11.88M
2021-09-30	-127.65	$1.27B	-$9.98M
2021-06-30	-253.21	$2.1B	-$8.29M
2021-03-31	-359.63	$2.19B	-$6.1M
2020-12-31	-379.19	$2.05B	-$5.4M
2020-09-30	-291.05	$1.09B	-$3.75M
2020-06-30	-600.21	$1.27B	-$2.12M
2020-03-31	-3,335.25	$1.25B	-$375,000.00
2019-12-31	935.11	$2.45B	$2.62M
2019-09-30	533.16	$2.64B	$4.94M
2019-06-30	665.89	$4.93B	$7.41M
2019-03-31	542.83	$5.44B	$10.03M
2018-12-31	464.84	$3.83B	$8.23M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.66	$49.78M	$18.73M
2025-12-31	-560.18	$20.73M	-$37,000.00
2024-12-31	92.92	$47.2M	$508,000.00
2023-12-31	-1.03	$33.14M	-$32.29M
2022-12-31	-0.56	$21.27M	-$37.78M
2021-12-31	-124.38	$1.48B	-$11.88M
2020-12-31	-379.19	$2.05B	-$5.4M
2019-12-31	935.11	$2.45B	$2.62M
2018-12-31	464.84	$3.83B	$8.23M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Clene Inc. (CLNN)	United States	$0.054B	-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)	United States	$0.055B	-2.38
Xilio Therapeutics, Inc. (XLO)	United States	$0.052B
Annovis Bio, Inc. (ANVS)	United States	$0.056B	-1.58
NOMAD POWER SOLUTIONS, INC. (NMAD)	United States	$0.058B
Boundless Bio, Inc. (BOLD)	United States	$0.059B	-0.88
Elicio Therapeutics, Inc. (ELTX)	United States	$0.049B
Lite Strategy, Inc. (LITS)	United States	$0.049B
Dogwood Therapeutics, Inc. (DWTX)	United States	$0.049B
TALPHERA, INC. (TLPH)	United States	$0.060B